Topic: vaccine development
An initial analysis showed that J&J's four-strain HIV vaccine elicited a broader immune response than an older trivalent version.
Vaxart touted phase 2 data for its oral flu vaccine candidate in a trial against Sanofi's market-leading Fluzone.
In its latest development deal, the outbreak readiness group CEPI has awarded J&J and Oxford University $14.6 million for work on a MERS vaccine.
Right on the heels of last week's deal in Lassa fever, CEPI has awarded IDT Biologika up to $36 million for MERS research.
Profectus’ Lassa candidate is based on its VesiculoVax vaccine delivery platform, which uses vesicular stomatitis virus as vector.
GSK, Merck, Sanofi, Pfizer and Seqirus topped the world's biggest vaccine companies list by 2017 revenue.